Pathway participated last week in the American Society for Reproductive Medicine’s (ASRM) 66th Annual Meeting in Denver, Colorado.
At our booth and during the Pathway-sponsored cocktail hour, we had the pleasure of meeting and conferring with a wide array of people in the field, and we had the opportunity to hear about new developments in the field of reproductive medicine.
One of the many highlights of the conference was a focus on several genetic testing and screening studies aimed at improving assisted reproductive technology success. “It’s exciting to see new research information being presented and screening that can be implemented to help prospective parents achieve and maintain a successful pregnancy,” said one of the conference’s attendees.
During the conference, Pathway also made known its distribution agreements with two leading companies in the field – The Apothecary Shops, a leading national specialty pharmacy based in Phoenix, Arizona, as well Reprogenetics, a New Jersey-based private genetics laboratory specializing in preimplantation genetic diagnosis (PGD).
The two companies will offer the Pre-Pregnancy Planning Insight™, Pathway’s extended carrier status genetic testing service, which screens for mutations causing over 70 recessive genetic conditions.
“Pathway Genomics is excited to enter into these agreements in the distribution of our carrier status service,” said Jim Plante, founder and CEO of Pathway Genomics. “We embrace the opportunity to help more people make informed decisions, and this certainly is an important step in that direction.”
Pathway wholly agrees with ASRM’s mission to advance “the art, science, and practice of reproductive medicine,” and we are glad to contribute our part to this endeavor with our extended carrier status genetic testing service.
Photos from the conference: